Increased levels of IL-6 9-11, IL-1 12, IL-8 13, IL-12 and IL-18 14 have been reported in the plasma in ESCC patients and correlated to poor prognosis or adverse clinical (or pathological) changes in ESCC. Here, IL6 is linked to esophageal squamous cell carcinoma.